CAS No. |
1858168-59-8 |
|---|---|
英文名称 |
- |
别名 |
Tislelizumab;Research Grade Tislelizumab(DHH02206);Research Grade Tislelizumab;Tislelizumab (anti-PDCD1) |
用途 |
Treatment of relapsed or refractory classical Hodgkin lymphoma (r/rcHL); treatment of urothelial carcinoma; clinical development for hepatocellular carcinoma, non-small cell lung cancer, and nasopharyngeal carcinoma. |
|
|
评论 |
|---|